 "Strides-Arcolab")
On the back of an exceptional gain, the pharmaceutical company Strides Arcolab today reported a gigantic increase in net profit at Rs 3,525 crore for the quarter ended December 2013. It was Rs 74 crore in the same period a year ago.
The company made an exceptional gain of Rs 3,265 crore by selling Agila to Mylan.
The total income has increased five-fold to Rs 1,642 crore as against Rs 261 crore in December 2012.
On Friday at 1350 hours the company's stocks on BSE were trading 1.2% higher at Rs 384 apiece.
